Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants - Paes, Bosco; Lanari, Marcello; Rodgers-Gray, Barry; Fullarton, John; Carbonell-Estrany, Xavier (Frontiers in Pediatrics, 2024)